August 14, 2019 Acad, Gov/Utilities Clinical Research/Diagn. Liq. Handling & Robotics Product Launch

QIAGEN’s new QIAstat-Dx Gastrointestinal Panel demonstrates excellent performance in multicenter clinical study in Europe

Hilden, Germany, and Germantown, Maryland, August 14, 2019 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the publication of a multicenter clinical study demonstrating the accuracy of its QIAstat-Dx syndromic testing solution for diagnosing the causes of acute gastroenteritis. The QIAstat-Dx Gastrointestinal Panel delivered high performance compared to other, existing multiplex tests in this... Read more

August 5, 2019 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 Product Launch

New Expanded Analytical Instrument Portfolio of U.S. FDA Class I Medical Devices for Clinical Diagnostic Laboratories

New Expanded Analytical Instrument Portfolio of U.S. FDA Class I Medical Devices for Clinical Diagnostic Laboratories Thermo Scientific Medical Device portfolio provides an extensive range of chromatography and mass spectrometry instruments for performing laboratory developed tests ANAHEIM, Calif. – AACC 2019 – (August 6, 2019) – Thermo Fisher Scientific has expanded its portfolio of analytical... Read more

July 31, 2019 Acad, Gov/Utilities Atomic Spectroscopy Bio/Pharma/CRO Chromatography Clinical Research/Diagn. Lab Top-10

Agilent Companion Diagnostic Gains Expanded FDA Approval in Esophageal Squamous Cell Carcinoma (ESCC)

Agilent Companion Diagnostic Gains Expanded FDA Approval in Esophageal Squamous Cell Carcinoma (ESCC) PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify ESCC patients SANTA CLARA, Calif., July 31, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s PD-L1 IHC... Read more

July 30, 2019 Acad, Gov/Utilities Lab Top-10 M&A, Partnerships

Canadian Government-Sponsored Collaboration Targets Standardized Cancer Testing

Genome Canada, Ontario Institute for Cancer Research and Thermo Fisher Scientific to focus on pancreatic, prostate and breast cancer CARLSBAD, Calif., July 30, 2019 /PRNewswire/ — Genome Canada, the Ontario Institute for Cancer Research (OICR) and Thermo Fisher Scientific are collaborating to develop a complete solution of targeted next generation sequencing (NGS) assays and analysis... Read more

July 1, 2019 Acad, Gov/Utilities

Luminex Submits ARIES MRSA Assay for FDA Clearance

AUSTIN, Texas, July 1, 2019 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) announced that the company submitted the ARIES® MRSA Assay to the U.S. Food and Drug Administration (FDA) for clearance on Friday, June 28, 2019. The assay is a qualitative polymerase chain reaction (PCR)-based, in vitro diagnostic test for the direct detection of methicillin-resistant Staphylococcus aureus... Read more

June 20, 2019 Acad, Gov/Utilities Microscopy

BD Statement on FDA Circulatory System Devices Panel Regarding Paclitaxel-Coated Devices

FRANKLIN LAKES, N.J., June 20, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement following the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting related to the potential increase in mortality associated with the use... Read more

June 20, 2019 Acad, Gov/Utilities Lab Top-10

MilliporeSigma Introduces Mobile Laboratory to Promote Protein Research

Company’s mobile lab to visit 20 campuses across China, sharing protein research knowledge through live digital demonstrations Shanghai, China, June 20, 2019 — MilliporeSigma, a leading science and technology company, today announced a national campus tour in China for the company’s first mobile protein research laboratory. The retrofitted van, converted into a lab on wheels, is... Read more

June 17, 2019 Acad, Gov/Utilities Chromatography M&A, Partnerships

Grace Acquires the Business of Rive Technology, Inc.

COLUMBIA, Md., June 17, 2019 (GLOBE NEWSWIRE) — W. R. Grace & Co. (NYSE:GRA) today completed the acquisition of the business  and assets of Rive Technology, Inc., including its Molecular Highway™ zeolite technology. As part of the transaction, certain research and development, technical services, and commercial employees will join Grace. Financial details of the transaction... Read more